AGREEMENT BETWEEN HEMOCUE AND GLUCOSE OXIDASE METHODS FOR BLOOD GLUCOSE MEASUREMENT IN A FIELD WORK STUDY OF DIABETES: THE COMCAAC PROJECT

Ana Cristina Gallegos Aguilar, Julian Esparza Romero, Héctor Hiram Hernández Martínez, Rene Urquídez Romero, Antonio Rascón Careaga, Enrique Bolado Martínez, Rolando Giovanni Díaz Zavala

Resumen


Los medidores de glucosa se utilizan para ayudar al profesional de la salud a monitorear y detectar alteraciones de la glucosa sanguínea (GS). El objetivo fue comparar la técnica de HemoCue (HC) versus glucosa oxidasa (GOx) para la medición de GS utilizando 368 mediciones de GS por ambos métodos. Se utilizaron gráficos de Bland & Altman, prueba de t-pareada y regresión lineal para su comparación. Se encontró concordancia entre los métodos en la mayoría de los niveles de glucosa, excepto a concentraciones de glucosa ≥ 6.993 mmol/L. El analizador de glucosa HC es bueno para su uso en estudios de campo ya que es técnicamente fácil y requiere muy poco mantenimiento; sin embargo, se recomienda tener especial cuidado con aquellas personas cuyos valores de glucosa están dentro del límite del diagnóstico de diabetes ya que, con el método HC, existe el riesgo de clasificar erróneamente a las personas que ya tienen diabetes como no diabéticas. Por lo tanto, dada la importancia de conocer los valores reales de los niveles de glucosa en este grupo de personas para un diagnóstico preciso, se recomienda considerar un análisis posterior con el método GOx para corroborar el resultado.


Palabras clave


Glucosa sanguínea; HemoCue; Glucosa Oxidasa

Texto completo:

PDF (English)

Referencias


ADA. 2015. Standards of Medical Care in Diabetes. American Diabetes Association. Diabetes Care. 38:1 S1-S94.

Bellini C., Serra G., Risso D., Mazzella M., y Bonioli E. 2007. Reliability assessment of glucose measurement by HemoCue analyzer in a neonatal intensive care unit. Clin Chem Lab Med. 45(11):1549-54.

Bland J.M. y Altman D.G. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1(8476):307-310.

Clarke S.F. y Foster J.R. 2012. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. British Journal of Biomedical Science. 69(2):83-93.

Dohnal L., Kalousová M., y Zima T. 2010. Reference Comparison of Three Methods for Determination of Glucose Laboratory for Clinical Chemistry. Prague Medical Report. 111(1): 42–54.

Ignell C. y Berntorp K. 2011. Evaluation of the relationship between capillary and venous plasma glucose concentrations obtained by the Hemocue Glucose 201+ system during an oral glucose tolerance test. Scandinavian Journal of Clinical & Laboratory Investigation, 71(8), 670-675.

Leonard M., Chessall M., y Manning D. 1997. The use of a Hemocue blood glucose analyzer in a neonatal unit. Ann Clin Biochem. 34 (Pt 3):287-90.

Marley J., Davis S., Coleman K., Hayhow B., Brennan G., Mein J., Nelson C., Atkinson D., y Maguire G. 2007. Point-of-care testing of capillary glucose in the exclusion and diagnosis of diabetes in remote Australia. Med J Aust. 186(10):500-503.

Meyer C., Schletzer-Mari A., Arcanger B., Leroux R., Lecomte F., Coconnier E., y Lucas F. 1998. Quality control of blood glucose meters is a must. Diabetes & metabolism. 24,455-457.

Pfützner A., Mitri M., Musholt P.B., Sachsenheimer D., Borchert M., Yap A., y Forst T. 2012. Clinical assessment of the accuracy of blood glucose measurement devices. Current Medical Research & Opinion. 28(4): 525–531.

Reach G. y Wilson G.S. 1992. Can continuous glucose monitoring be used for the treatment of diabetes? Anal Chem. 64(6):381A-386A.

Rebel A., Rice M.A., y Fahy B.G. 2012. Journal of Diabetes Science and Technology. 6(2):396-411. www.journalofdst.org.

Reddy S., Sumathi M., Gowda B., y Suhail M. 2014. Comparison of Point of Care (POC) Testing of Glucose by B Braun Glucometer and Hemocue Glucose 201+ Analyzer versus Centralized Testing in Neonatal Intensive Care Unit (NICU). J Clin Diagn Res. 8(7): PC10-PC13.

Robles-Ordaz, M., Gallegos-Aguilar, A., Urquidez-Romero, R., Diaz-Zavala, R., Lavandera-Torres, M., & Esparza-Romero, J. 2018. Prevalence of prediabetes and modifiable factors in an ethnic group of Mexico: The Comcáac Project. Public Health Nutrition. 21(2): 333-338. doi:10.1017/S1368980017002658

Sacks DB., Arnold M., Bakris GL., Bruns DE., Horvath AR., Kirkman MS., Lernmark A., Metzger BE., y Nathan DM. 2011. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Reviews/Commentaries/ADA Statements. Position Statement. Diabetes Care. 34: e61-e99.

Salacinski A.J., Alford M., Drevets K., Hart S., y Hunt B.E. 2014. Validity and Reliability of a Glucometer against Industry Reference Standards. Journal of Diabetes Science and Technology. 8(1): 95– 99.

Stork A.D.M., Kemperman H., Erkelens D.W., y Veneman T.F. 2005. Comparison of the accuracy of the hemocue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia. European Journal of Endocrinology. 153: 275–281. ISSN 0804-4643.

Sudha R., Sumathi, G.B., y Suhail S. 2014. Comparison of Point

Hemocue Glucose. Journal of Clinical and Diagnostic Research. 8(7): PC10-PC13.

Tonyushkina K., y Nichol J.H. 2009. Glucose Meters: A Review of Technical Challenges to Obtaining Accurate Results. Journal of Diabetes Science and Technology. 3(4): 971-980. www.journalofdst.org.

Torjman M.C., Jahn L., Joseph J.I., Crothall K., y Goldstein B.J. 2001. Accuracy of the HemoCue Portable Glucose Analyzer in a Large Nonhomogeneous Population. Diabetes Technol Ther. Winter. 3(4):591-600.

Turner A.P.1., Chen B., y Piletsky S.A. 1999. In vitro diagnostics in diabetes: meeting the challenge. Clin Chem. 45(9):1596-601.

Urquidez Romero R., Esparza-Romero J., Chaudhari L., Begay R., Giraldo M., Ravussin E., Knowler W., Hanson R., Bennet P., Schulz L., y Valencia M. 2014. Study of the Maycoba Proyect: Obesity and Diabetes in Mexican Pimas. AM J Health Behav. 38(3):370-378.

Wang J. 2001. Glucose Biosensors: 40 Years of Advances and Challenges. Electroanalysis. 13(12): 983–988.

Warner J.V., Wu J.Y., Buckingham N., McLeod D.S.A., Mottram B., y Carter A,C. 2011. Can One Point-Of-Care Glucose Meter Be Used for All Pediatric and Adult Hospital Patients? Evaluation of Three Meters, Including Recently Modified Test Strips. Diabetes Technology & Therapeutics. 13(1): 55-62.




DOI: http://dx.doi.org/10.18633/biotecnia.v21i1.809

Enlaces refback

  • No hay ningún enlace refback.